ICON and Advarra Launch Connected Site Network for Clinical Trials
Event summary
- ICON plc (NASDAQ: ICLR) partners with Advarra to create a 'research-ready' connected site network model for clinical trials.
- Integration combines ICON’s global trial solutions with Advarra’s site CTMSs, eISF, and eSource systems used by 50,000 investigators worldwide.
- Partnership aims to reduce administrative friction, accelerate study startup, and increase trial participation.
- Advarra’s Study Collaboration platform will provide ICON with operational intelligence for protocol design and study planning.
The big picture
This partnership aligns with the broader industry trend of leveraging technology and data to streamline clinical trial operations. By integrating their platforms, ICON and Advarra aim to reduce inefficiencies in trial execution, a critical factor as sponsors seek faster and more reliable pathways to market for new therapies.
What we're watching
- Operational Efficiency
- How the integration of ICON’s and Advarra’s systems will affect study startup times and administrative burden on research sites.
- Data Utilization
- Whether Advarra’s operational intelligence will significantly improve protocol design and study planning for ICON.
- Market Expansion
- The pace at which the partnership can equip emerging research sites with necessary technology to support complex studies.
Related topics